Top 5 Fastest Growing Nuclear Power Stocks to Watch Out for in 2025
India's Soaring Power Demand, Fuelled By Urbanisation, EV Adoption, Underscores The Need For Stronger Energy Infrastructure. ⚡📈
A Detailed Thread On 5 Stocks🧵
Bookmark And Analyse This Sector!
Nuclear energy stands out due to its reliable and continuous energy supply. It emits minimal carbon emissions and generates a high energy from little fuel. It also enhances energy security by reducing dependence on fossil fuel imports.
The benefits have encouraged countries worldwide to produce more electricity using nuclear power.
Nuclear power is vital for India's energy landscape and is growing at an impressive rate-it's actually doubling the pace of global growth.
According to the Energy Institute in the UK, in 2023, nuclear power generation in India surged 4.4%, compared to just 2.2% worldwide. It has 24 nuclear power reactors, which generated 47,971 million units last year.
In the past decade, India's nuclear power capacity has skyrocketed over 70%, from 4,780 megawatts (MW) in 2013-14 to 8,180 MW. This is expected to grow rapidly in the coming year as the country's power requirements and the demand for net-zero emissions grow.
Consequently, the government intends to triple the capacity to 22,480 MW by 2031-32 and aims for 100,000 MW by 2047.
5 Stocks That Stand to Benefit from the Government's Decision to Curb Soda Ash Imports.
Bookmark and Analyse📊
A Thread on 5 Stocks🧵
The Indian government just dropped a game-changer for local industries, imposing a minimum import price (MIP) on soda ash.
The Indian government has imposed a MIP of Rs 20,108 per tonne on soda ash until 30 June 2025. This decision, communicated by the Directorate General of Foreign Trade (DGFT), aims to curb the inflow of lower-cost imports and protect the local manufacturing sector.
Following 30 June 2025, the country will revert to its previous policy allowing free imports of the commodity.
Soda ash is the secret sauce for making detergents, glass, and chemicals.
Top 5 Drone Stocks to Watch Out for Multibagger Returns in 2025.
Bookmark this Thread and Analyse📊
Detailed View on 5 Stocks🧵
The global drone market is experiencing a big boom, projected to reach US$ 54 billion (bn) by 2025 and potentially US $91.3 bn by 2030.
This growth trajectory provides a strong tailwind for companies operating in this space.
India is actively positioning itself as a global leader in the drone industry, aiming to become a major drone hub by 2030. Government initiatives and a conducive regulatory environment back this ambition.
The Indian government's product-linked incentive (PLI) scheme, launched in 2021, has already disbursed Rs 300 million (m) out of a total incentive pool of Rs 1,200 m, boosting the industry's growth.
10 Chemical Stocks that Could Thrive as the Battery Materials Industry Grows🔋
A Detailed Thread on 10 Stocks.
Bookmark and Analyse🧵
The battery chemical ecosystem is at the heart of the global push for clean energy and sustainable technology.
This ecosystem includes companies that manufacture essential chemicals and materials powering batteries that are used in electric vehicles (EVs) as well as batteries used in advanced grid storage solutions.
This ecosystem encompasses diverse sectors, from speciality chemicals and fluoropolymers to carbon black and lithium derivatives.
1. Himadri Speciality Chemical
Himadri Speciality Chemical is primarily engaged in the manufacturing of carbon materials and chemicals. As a matter of fact, it's the only company to manufacture advanced carbon materials in India.
It serves a diverse range of industries, such as lithium-ion batteries, paints, plastics, tyres, and aluminium, among others.
Himadri is also a prominent player in multiple speciality carbon product segments like coal tar pitch, carbon black, naphthalene, refined naphthalene, SNF, and speciality oils, among others.
The company derives roughly 86% of its revenues from the Indian market and the balance 14% from exports.
It Covers Fundamentals and Technical Levels of the Company 🧵
About the company:
Par drugs presently engaged in the development and manufacture of Active Pharma Ingredients ("APIs") for the domestic market as well as for exports to international markets.
Currently producing various range of Antacid Molecules which are available in the market and are in great demand.
Key products:
The company manufactures the entire range of products in the Antacid Molecules segment. The product portfolio presently comprises 18 APIs and 10 Fine Chemicals which are marketed domestically and also exported.